Use of cotrimoxazole prophylaxis in HIV infected in patients at a referral hospital.
Cent Afr J Med
; 56(5-8): 26-30, 2010.
Article
em En
| MEDLINE
| ID: mdl-23457847
ABSTRACT
OBJECTIVE:
To assess the extent of use of cotrimoxazole prophylaxis in the prevention of opportunistic infections in HIV infected patients.SETTING:
Parirenyatwa Hospital, a major referral and teaching hospital.DESIGN:
A retrospective study.SUBJECTS:
234 HIV infected patients admitted between January and June 2004, with a history of symptoms falling into the WHO stage 3 AIDS, were included. MAIN OUTCOMEMEASURES:
Cotrimoxazole prophylaxis, PCP prevalence, and mortality.RESULTS:
234 patients' records were reviewed and 19% of the patients had received cotrimoxazole prophylaxis. PCP prevalence was 36% which was diagnosed mainly by clinical examination and sometimes with the additional help of chest X-rays. Of those who were on prophylaxis, 75% were on primary prophylaxis and the rest on secondary prophylaxis. All patients on prophylaxis were using cotrimoxazole, with the 960 mg once daily dosing being the most common regimen (96%). Receiving prophylaxis was associated with being female (p = 0.0067), widowed (p = 0.012), and taking ARV therapy (p = 0.0026). Prophylaxis significantly reduced mortality (p = 0.0017). The development of PCP was associated with a history oftuberculosis relapse (p = 0.022).CONCLUSION:
Cotrimoxazole prophylaxis is important in reducing hospital admissions due to opportunistic infections and increasing survival especially in areas with limited access to antiretroviral therapy.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Pneumonia por Pneumocystis
/
Combinação Trimetoprima e Sulfametoxazol
/
Infecções Oportunistas Relacionadas com a AIDS
/
Anti-Infecciosos
Tipo de estudo:
Observational_studies
/
Risk_factors_studies
Limite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Cent Afr J Med
Ano de publicação:
2010
Tipo de documento:
Article